ja
INVESTORS

FAQS

Explore Our FAQs

CORPORATE INFORMATION
Q. When was the company established?
A.

June 7, 2005.

Q. When was the company listed on the stock market?
A.

October 27, 2008.

STOCK INFORMATION
Q. On which market are the stocks listed?
A. The Standard Section of the Tokyo Stock Exchange.
Q. What is the stock code?
A. 2183.
Q. How many shares make up a trading unit?
A. 100 shares.
Q. When are the accounts settled?
A. March 31.
Q. When are financial results announced?
A. We schedule them for early May.
Q. When is the General Meeting of Shareholders held?
A. We schedule it for mid- to late June.
Q. Are there any special benefit plans for shareholders?
A. At present, there are no special benefit plans.
Q. Who manages the shareholders' list?
A. Mitsubishi UFJ Trust and Banking Corporation.
Q. Osaka Stock Handling Department, Mitsubishi UFJ Trust and Banking Corporation
A. Tel. 0120-094-777 (toll free)
GLOSSARY
Q. CRO
A.

CRO (Clinical Research Organization) normally refers to a body for accepting the consignment of aspects of the medical drug development business in medical-related fields.


It indicates corporations that can substitute for and support some of the business and other activities related to clinical trials during the medical drug development stage, and clinical trials after sales of medical drugs when they are being developed by pharmaceutical companies.

Q. CRA
A.

CRA (Clinical Research Associate) normally refers to a clinical development monitor (or clinical trial monitor). It indicates a person who monitors whether a clinical trial during the medical drug development stage is being performed in compliance with the Pharmaceutical Affairs Act and other related regulations, the clinical trial standard operating procedure, and the protocol.

Q. Monitoring Activities
A.

Monitoring is the central activity in the development of new drugs. A Clinical Research Associate (CRA), the person in charge of development, visits the medical institution and formally explains the clinical trial contract, explains the clinical trial drug to the doctors, describes the protocol, checks the status of compliance with the protocol, delivers the clinical trial drugs, requests cooperation with the clinical trial (integrates the clinical cases), ensures data reliability and collects the data.

Q. Quality Control (QC) Activities
A. Quality Control (QC) activities are the work of confirming that the monitoring is being performed properly according to the protocol and clinical trial standard operating procedure.
Q. Lorem ipsum dolor sit amet, consectetur adipiscing elit
A.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Want to learn more? Contact the Linical Investor Relations Team.

Get in Touch

Successful clinical trials start with Linical.

Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals. 

01 Request a proposal

We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.

02 Get a plan for success

We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.

03 Execute with confidence

We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.

cta-img (2)
Request a proposal from Linical, today